DILUMAREX

国家: 爱尔兰

语言: 英文

来源: HPRA (Health Products Regulatory Authority)

可用日期:

Merial Animal Health Limited

ATC代码:

QV07AB

剂量:

.

药物剂型:

Solution for injection

处方类型:

POM: Prescription Only Medicine as defined in relevant national legislation

治疗组:

Chickens

治疗领域:

Solvents and diluting agents, incl. irrigating solutions

疗效迹象:

Immunological - Diluent

授权状态:

Authorised

授权日期:

2005-11-18

产品特点

Health Products Regulatory Authority
21 February 2018
CRN000VWJ
Page 1 of 4
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
DILUMAREX
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Aqueous diluent
q.s. 1 ml
3 PHARMACEUTICAL FORM
Solution for injection.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Chickens.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
In chickens:
For the suspension preparation of MERIAL frozen vaccines against
Marek’s
disease.
4.3 CONTRAINDICATIONS
Do not use alone.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Read special precautions for use of MERIAL frozen vaccines against
Marek’s disease.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY
MEDICINAL PRODUCT TO ANIMALS
In the case of accidental self-injection, seek medical advice
immediately and show
the package leaflet
or the label to the physician.
Health Products Regulatory Authority
21 February 2018
CRN000VWJ
Page 2 of 4
4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
None.
4.7 USE DURING PREGNANCY, LACTATION OR LAY
Read corresponding information of MERIAL frozen vaccines against
Marek’s disease.
4.8 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
None.
4.9 AMOUNTS TO BE ADMINISTERED AND ADMINISTRATION ROUTE
Refer to posology and method of administration of MERIAL frozen
vaccines against Marek’s
disease.
4.10 OVERDOSE (SYMPTOMS, EMERGENCY PROCEDURES, ANTIDOTES), IF
NECESSARY
None.
4.11 WITHDRAWAL PERIOD(S)
Zero days.
5 PHARMACOLOGICAL OR IMMUNOLOGICAL PROPERTIES
Not applicable.
ATCvet code: QV07AB. Solvents and diluting agents, incl. irrigating
solutions.
6 PHARMACEUTICAL PARTICULARS
6.1 LIST OF EXCIPIENTS
Sucrose
Casein hydrolysate
Dipotassium phosphate
Potassium dihydrogen phosphate
Phenol red (1% solution)
Hydrochloric acid concentrated
Sodium hydroxide
Water for injections
Health Products Regulatory Authority
21 February 2018
CRN000VWJ
Page 3 of 4
6.2 MAJOR INCOMPATIBILITIES
Do not mix with any other medi